Results of renal artery stenting in patients with stage III–IV ischemic nephropathy

• Vachev A.N.
• Kamenev E.V.
• Frolova E.V.

Abstract

Background. After the ASTRAL (2009) and CORAL (2014) studies, many questions regarding renal artery stenting remained unanswered. First of all, it concerns defining the groups of patients in whom a good clinical effect of renal revascularization can be anticipated.

Objective. The purpose of this study was to assess the effect of renal artery stenting on the course of stage III–IV chronic ischemic kidney disease in patients with significant renal artery stenosis (>70%).

Patients and methods. Our single-center, retrospective-prospective study enrolled a total of 158 patients with a hemodynamically significant renal artery stenosis and confirmed stage III–IV chronic kidney disease. It was determined that progressing atherosclerotic renal artery stenosis was the main cause of the development of chronic kidney disease, since all other possible causes were ruled out. All patients were treated by a nephrologist but chronic kidney disease was progressing. These 158 patients besides medicamentous therapy were subjected to an operation in the scope of renal artery angioplasty and stenting. The results of treatment were evaluated at discharge from hospital (up to 7 days), 1 month after surgery and then after 1, 3 and 5 years. The endpoints included the change in the stage of the disease, stabilization of the course of chronic kidney disease, and transfer to renal replacement therapy (programmed hemodialysis).

Results. Prior to renal artery stenting, the average glomerular filtration rate in our patients was 47.5±10.4 ml/min/1.73 m², amounting to 61.3±20.2 ml/min/1.73 m², 62.7±20.1 ml/min/1.73 m², and 55.2±19.4 ml/min/1.73 m², at discharge, after 1 year, and after 3 years, respectively. The difference turned out to be statistically significant (p<0.001). “Transformation” of the grades of chronic kidney disease before and after surgery was determined. We managed to improve or stabilize the course of ischemic nephropathy in 91.9% patients within a period of up to 12 months and in 89.7% – more than 1 year of follow-up. We succeeded to avoid switching to renal replacement therapy in 11 patients with the glomerular filtration rate less than 30 ml/min/1.73 m². Prognostically meaningful factors influencing the outcome after renal artery stenting were found to be as follows: diabetes mellitus (HR 0.234; p=0.003), renal arcuate arteries resistive index less than 0.8 (HR 0.274), and an initially pronounced decrease in the glomerular filtration rate (C4 chronic kidney disease) (HR 0.219; p=0.006). A clear correlation was revealed between persistence of the clinical effect and the duration of chronic kidney disease prior to renal revascularization.

Conclusion. The presence of a significant renal artery stenosis in a patient with stage III–IV chronic ischemic kidney disease should be considered as an indication for renal revascularization. Such strategy results in improvement of the renal function for a period of not less than 3 years.

Funding. The study had no financial support.

Conflict of interest. The authors declare no conflicts of interest.

Authors’ contribution. Study conception and design – Vachev A.N., Frolova E.V.; data collection and handling – Kamenev E.V.; statistical processing – Kamenev E.V.; draft manuscript preparation – Frolova E.V., Kamenev E.V.; manuscript revision – Vachev A.N.

For citation: Vachev A.N., Kamenev E.V., Frolova E.V. Results of renal artery stenting in patients with stage III–IV ischemic nephropathy. Angiology and Vascular Surgery. Journal named after Academician A.V. Pokrovsky. 2024; 30 (2): 80–7. DOI: https://doi.org/10.33029/1027-6661-2024-30-2-80-87

Keywords: renal artery stenosis; atherosclerosis; ischemic nephropathy; renal revascularization; renal artery stenting

References

1. Cooper C., Murphy T., Cutlip D., et al. Stenting and medical therapy for atherosclerotic renal-artery. New England Journal of Medicine. 2014; 370 (1): 13–22. DOI: https://doi.org/10.1056/NEJMoa1310753

2. Gupta R., Assiri S., Cooper C.J. ^.Renal Artery Stenosis: New Findings from the CORAL Trial. Current Cardiology Reports. 2017; 19 (9): 75. DOI: https://doi.org/10.1007/s11886-017-0894-2

3. Misra S., Khosla A., Allrede J., et al. Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease. Journal of Vascular and Interventional Radiology. 2016; 27 (8): 1215–1224. DOI: https://doi.org/10.1016/j.jvir.2016.05.001

4. Weinberg M.D., Olin J.W. Stenting for atherosclerotic renal artery stenosis: one poorly designed trial after another. Cleveland Clinic Journal of Medicine. 2018; 77 (3): 164–171. DOI: https://doi.org/10.3949/ccjm.77a.10001

5. Mohan I.V., Bourke V. The management of renal artery stenosis:an alternative interpretation of ASTRAL and CORAL. European Journal of Vascular and Endovascular Surgery. 2015; 49 (4): 465–473. DOI: https://doi.org/10.1016/j.ejvs.2014.12.026

6. Modrall J.G., Trimmer C., Tsai S., et al. Renal Salvage with Renal Artery Stenting Improves Long-term Survival. Annals of Vascular Surgery. 2017; 45: 106–111. DOI: https://doi.org/10.1016/j.avsg.2017.05.033

7. Karanikola E., Karaolanis G., Galyfos G., et al. Endovascular management of atherosclerotic renal artery stenosis: post-cardiovascular outcomes in renal atherosclerotic lesions era winner or false alarm? Vascular Specialist International. 2017; 33 (1): 1–15. DOI: https://doi.org/10.5758/vsi.2017.33.1.1

8. Prince M., Tafur J.D., White C.J. When and how should we revascularize patients with atherosclerotic renal artery stenosis? JACC: Cardiovascular Interventions. 2019; 12 (6): 505–517. DOI: https://doi.org/10.1016/j.jcin.2018.10.023

9. Riaz I.B., Husnain M., Riaz H., Asawaeer M. Meta-analysis of revascularization versus medical therapy for atherosclerotic renal artery stenosis. American Journal of Cardiology. 2014; 114 (7): 1116–1123. DOI: https://doi.org/10.1016/j.amjcard.2014.06.033

10. Bavry A.A., Kapadia S.R., Bhatt D.L., Kumbhani D.J. Renal artery revascularization: updated meta-analysis with the CORAL trial. JAMA Internal Medicine. 2014; 174 (11): 1849–1851. DOI: https://doi.org/10.1001/jamainternmed.2014.4332

11. White C.J. Kiss my astral: one seriously flawed study of renal stenting after another. Catheterization and Cardiovascular Interventions. 2010; 75 (2): 305–307. DOI: https://doi.org/10.1002/ccd.22416

12. Modrall J.G., Zhu H., Prasad T., et al. Retrieval of renal function after renal artery stenting improves event-free survival in a sub-group analysis of the Cardiovascular Outcomes in Renal Atherosclerotic Lesions Trial. Journal of Vascular Surgery. 2023; 77 (6): 1685–1692.e2. DOI: https://doi.org/10.1016/j.jvs.2022.12.067

13.  Parikh S., Shishebor M., Gray B., et al. SCAI expert consensus statement for renal artery stenting appropriate use. Catheterization and Cardiovascular Interventions. 2017; 84 (7): 1163–1171. DOI: https://doi.org/10.1002/ccd.25559

14.  Li Y., Ma N., Zhang Y., et al. Development and validation of a prognostic nomogram for prognosis in patients with renal artery stenosis. Frontiers of Medicine. 2022; 9: 783994. DOI: https://doi.org/10.3389\fmed.2022.783994

15. Iwashima Y., Fukuda T., Horio T., et al. Association between renal function and outcomes after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis. Journal of Hypertension. 2018; 36 (1): 126–135. DOI: https://doi.org/10.1097/HJH.0000000000001499

16. Fay K.S., Cohen D.L. Resistant hypertension in people with CKD: a review. American Journal of Kidney Diseases. 2021; 77 (1): 110–121. DOI: https://doi.org/10.1053/j.ajkd.2020.04.017

17. Cooper E.L., Xie Y., Nguyen H., et al. Early Rapid Decline in Kidney Function in Medically Managed Patients With Atherosclerotic Renal Artery Stenosis. Journal of the American Heart Association. 2019; 8 (11): e012366. DOI: https://doi.org/10.1161/JAHA.119.012366

18.  Manaktala R., Tafur-Soto J.D., White C.J. Renal artery stenosis in the patient with hypertension: prevalence, impact and management. Integrated Blood Pressure Control. 2020; 13: 71–82. DOI: https://doi.org/10.2147/IBPC.S248579

19.  Perkovi V., Thomson K.R., Becker G.J. Factors affecting outcome after percutaneous renal arterystent insertion. Journal of Nephrology. 2002; 15 (6): 649–654.

20. Thatipelli M., Misra S., Johnson C.M., et al. Renal artery stent placement for restoration of renal function in hemodialysis recipients with renal artery stenosis. Journal of Vascular and Interventional Radiology. 2008; 19 (11): 1563–1568. DOI: https://doi.org/10.1016/j.jvir.2008.08.016

21.  Modrall J.G., Jeon-Slaughter H., Ramanan B., et al. Predicting renal function response to renal artery stenting. Journal of Vascular Surgery. 2023; 78 (1): 102–110.e1. DOI: https://doi.org/10.1016/j.jvs.2023.02.010